Blog - Page 484 of 5639 - QualityStocks

ThursdayMar 21, 2024 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Developing Pipeline to Address Unmet Needs in Autism Spectrum Disorder via Suramin Sodium

Autism (“ASD”) is a global problem, with no generally accepted treatment. In the UK alone, between 1998 and 2018, research has found a greater than 780% increase in the number of autism cases PaxMedica is focused on the development of novel anti-purinergic therapies (“APTs”) for the treatment of ASD and other serious conditions with intractable neurologic symptoms The ASD therapeutics market was valued at $2.01 billion in 2023 and is expected to reach $3.42 billion by 2030, growing at a CAGR of 7.9% There is currently no approved pharmacologic treatment targeting the cause and symptoms. Current treatments only address the…

ThursdayMar 21, 2024 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Go-to-Market Growth Strategy and Upcoming Participation in 36th Annual Roth Conference

D-Wave’s new go-to-market (“GTM”) growth strategy, initially focused on key verticals, including logistics, manufacturing, and government, is expected to accelerate the adoption and deployment of commercial quantum technologies The GTM approach reinforces the value of the company’s unique annealing quantum computing solutions, which help organizations solve highly complex computational problems today According to Hyperion Research, over 80% of enterprises are expected to increase their investments in quantum computing over the next two to three years, with logistics and supply chain management identified as top sectors to benefit from quantum computing capabilities D-Wave Quantum (NYSE: QBTS), a leader in quantum computing…

ThursdayMar 21, 2024 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-CBD Achieves 7% Weight Loss; Sets Stage for 8-week Diabetes and Weight Loss Animal Study

Lexaria, a global innovator in drug delivery platforms, highlighted results from its DIAB-A22-1 animal study, highlighting a 7% reduction in weight and a 19.9% reduction in blood glucose With this success, Lexaria looks to kick off its WEIGHT-A24-1 animal study to examine diabetes and weight loss effects of its patented DehydraTECH(TM)-processed GLP-1 drugs and DehydraTECH-processed CBD The study will comprise 12 arms and involve 72 animals. It will run for a total of 12 weeks This study will build on previous studies that evidenced DehydraTECH’s potential to enable greater penetration of GLP-1 drugs into the brain tissue Lexaria Bioscience (NASDAQ:…

WednesdayMar 20, 2024 3:45 pm

QualityStocksNewsBreaks – Why Zoned Properties Inc. (ZDPY) Is ‘One to Watch’

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focused on acquiring value-add real estate within the U.S. regulated cannabis industry. “The company aspires to innovate, focusing on direct-to-consumer real estate that is leased to best-in-class cannabis retailers. The company is redefining the approach to commercial real estate investment through its standardized process backed by its proprietary property technology. Zoned Properties has developed a national ecosystem of real estate services to support its real estate development process, including a commercial real estate brokerage and a real estate advisory practice… The company targets commercial…

WednesdayMar 20, 2024 3:05 pm

QualityStocksNewsBreaks – GEMXX Corp. (GEMZ) Laying Foundation for Sustainable Long-Term Growth

GEMXX (OTC: GEMZ), a mining and jewelry-making company, specializes in the mining of ammolite, a rare, opal-like gemstone that is only found on the eastern slopes of the Rocky Mountains in Southern Alberta. Last year, the company expanded into the mining of gold to complement the historical resources that undergird its jewelry production strategy. “On Feb. 13, the company reported product deliveries worth $1,051,374 at retail for the month of January, highlighting the success of GEMXX’s focus on operational efficiency and production of high-margin products… GEMXX plans to build on the year-opening report with further investments in exploration, drilling, surveys,…

WednesdayMar 20, 2024 1:40 pm

QualityStocksNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD Patients

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”), is focusing its lead program on autism spectrum disorder (“ASD”), for which there is no approved pharmacologic treatment targeting cause and symptoms. “The current ASD treatments only address the symptoms of the condition but do not target the pathophysiology itself. PaxMedica is on a promising path to address the unmet medical needs of families with ASD – bringing hope to millions,” a recent article reads. “PaxMedica is using existing research on a drug called suramin, initially created to treat a disease called Human African…

WednesdayMar 20, 2024 1:11 pm

QualityStocksNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Eko2o S.A.S Eyes Expansion into Costa Rica and Central America

Eko2o S.A.S., a leader in sustainable agricultural technologies and a majority-owned subsidiary of Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), today announced its strategic plans to expand operations into Costa Rica and the broader Central American market. The initiative aligns with Eko2o’s mission to promote sustainable agriculture and innovative technology solutions around the globe. “Costa Rica and Central America are regions known for their commitment to environmental sustainability and high agricultural potential. This makes them the perfect match for Eko2o’s mission and expertise,” said Juan Ricardo Velez, CEO of Eko2o. “We are excited about the opportunity to collaborate with local…

WednesdayMar 20, 2024 1:03 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Announces Leading PR Firm as Official Communications and Marketing Agency of Record

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, has selected Counsel Public Affairs as its communications and marketing agency of record; the two companies entered into an initial 12-month agreement. According to the announcement, FuelPositive conducted a thorough search and selected Counsel for its reputation as Canada’s most effective public affairs firm and because of its specialization in government relations, strategic communications and integrated campaigns. In addition to PR support, Counsel will provide investor relations communications support. “We are thrilled to welcome Counsel Public Affairs as our newly appointed agency of record,” said FuelPositive chief impact officer Luna…

WednesdayMar 20, 2024 12:54 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into definitive agreements. The agreements are for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) of the company and warrants to purchase up to 1,542,112 shares of common stock; the stocks and warrants are offered at a combined price of $4.215 per share of common stock (or per prefunded warrant in lieu thereof) and accompanying warrant. Genprex will be receive approximately $6.5 million in gross proceeds from the offering, before standard fees and…

WednesdayMar 20, 2024 12:28 pm

QualityStocksNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split of the company’s Class A common stock. The move was approved by the company’s board of directors during a special stockholder meeting. According to the announcement, the reverse split will become effective at 11:59 p.m. ET on March 26, 2024. Following that, the company’s Class A common stock will begin trading on the NASDAQ Capital Market on a split-adjusted basis. “The reverse split is intended to increase the per share trading price of the company’s common stock to enable the…

Site Search

Company Search